Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Hepatol. Jan 27, 2025; 17(1): 99183
Published online Jan 27, 2025. doi: 10.4254/wjh.v17.i1.99183
Table 2 Sample characterization categorized by Triceps skinfold and Child–Turcotte–Pugh score (n = 129), mean ± SD/n (%)
Descriptive variables
Categorized by TSF
P value
Categorized by Child–Turcotte–Pugh
P value
1
2
3
1
2
3
24 (18.6)
53 (41.09)
52 (40.31)
85 (65.89)
33 (25.58)
11 (8.53)
Gender0.0050.404
Male9 (37.5)26 (49.06)38 (73.08)45 (52.94)20 (60.61)8 (72.73)
Female15 (62.5)27 (50.94)14 (26.92)40 (47.06)13 (39.39)3 (27.27)
Death0.8170.013
Yes15 (62.5)29 (54.72)30 (57.69)41 (48.24)25 (75.76)8 (72.73)
No9 (37.5)24 (45.28)22 (42.31)44 (51.76)8 (24.24)3 (27.27)
Transplanted0.6830.025
No22 (91.67)45 (84.91)44 (84.62)78 (91.76)24 (72.73)9 (81.82)
Yes2 (8.33)8 (15.09)8 (15.38)7 (8.24)9 (27.27)2 (18.18)
Cirrhosis etiology0.9810.178
Alcohol4 (16.67)13 (24.53)14 (26.92)25 (29.41)4 (12.12)2 (18.18)
Autoimmune0 (0)3 (5.66)2 (3.85)5 (5.88)0 (0)0 (0)
Cryptogenic-NASH2 (8.33)2 (3.77)1 (1.92)3 (3.53)2 (6.06)0 (0)
Virus C + alcohol4 (16.67)4 (7.55)6 (11.54)9 (10.59)5 (15.15)0 (0)
Virus B + C + alcohol3 (12.5)6 (11.32)3 (5.77)5 (5.88)4 (12.12)3 (27.27)
Virus B + alcohol1 (4.17)0 (0)0 (0)0 (0)0 (0)1 (9.09)
Virus C0 (0)0 (0)1 (1.92)0 (0)1 (3.03)0 (0)
Virus B10 (41.67)23 (43.4)23 (44.23)36 (42.35)15 (45.45)5 (45.45)
Other0 (0)2 (3.77)2 (3.85)2 (2.35)2 (6.06)0 (0)
Ascites0.5190.001
Yes12 (50)34 (64.15)28 (53.85)40 (47.06)25 (75.76)9 (81.82)
No12 (50)19 (35.85)23 (44.23)45 (52.94)7 (21.21)2 (18.18)
Paracentesis0.9800.311
Yes8 (33.33)17 (32.08)14 (26.92)20 (23.53)13 (39.39)6 (54.55)
No16 (66.67)35 (66.04)36 (69.23)62 (72.94)20 (60.61)5 (45.45)
Esophageal varices0.6790.599
Yes19 (79.17)41 (77.36)37 (71.15)62 (72.94)27 (81.82)8 (72.73)
No5 (20.83)12 (22.64)15 (28.85)23 (27.06)6 (18.18)3 (27.27)
Varices bleeding0.2760.457
Yes4 (16.67)7 (13.21)3 (5.77)10 (11.76)3 (9.09)1 (9.09)
No19 (79.17)46 (86.79)48 (92.31)75 (88.24)28 (84.85)10 (90.91)
Encephalopathy0.4760.001
Yes10 (41.67)20 (37.74)15 (28.85)22 (25.88)14 (42.42)9 (81.82)
No14 (58.33)33 (62.26)37 (71.15)63 (74.12)19 (57.58)2 (18.18)
Encephalopathy level0.2990.001
014 (58.33)33 (62.26)37 (71.15)63 (74.12)19 (57.58)2 (18.18)
14 (16.67)6 (11.32)8 (15.38)11 (12.94)4 (12.12)3 (27.27)
22 (8.33)11 (20.75)5 (9.62)6 (7.06)8 (24.24)4 (36.36)
34 (16.67)3 (5.66)1 (1.92)4 (4.71)2 (6.06)2 (18.18)
40 (0)0 (0)1 (1.92)1 (1.18)0 (0)0 (0)
Developed HCC0.0790.576
Yes21 (87.5)52 (98.11)45 (86.54)77 (90.59)30 (90.91)11 (100)
No3 (12.5)1 (1.89)7 (13.46)8 (9.41)3 (9.09)0 (0)
Continuous variablesTSFP valueChild-Turcotte-PughP value
123123
24 (18.6)53 (41.09)52 (40.31)85 (65.89)33 (25.58)11 (8.53)
Age (yr)57.671 ± 8.83756.156 ± 12.20655.865 ± 11.3820.80455.942 ± 11.82558.424 ± 10.41752.937 ± 8.3850.328
Survival time (mo)98.715 ± 78.11116.068 ± 74.444111.258 ± 70.1850.631128.237 ± 68.00581.32 ± 70.68265.676 ± 77.1030.001
Survival time (yr)8.114 ± 6.429.54 ± 6.1199.144 ± 5.7690.63110.54 ± 5.5896.684 ± 5.8095.398 ± 6.3370.001
Height (cm)161.333 ± 8.731163.83 ± 8.733166.49 ± 90.053164.082 ± 8.597164.955 ± 9.518165.636 ± 10.8470.806
First assessment weight (kg)74.3 ± 10.43466.517 ± 10.93582.648 ± 15.3890.00072.445 ± 12.5478.991 ± 18.53976.527 ± 15.3370.083
Body mass index28.574 ± 4.05224.816 ± 3.7629.811 ± 4.8720.00026.868 ± 4.1729.131 ± 6.00527.821 ± 5.2280.073
Arm circumference (cm)31.222 ± 3.00127.674 ± 3.96833 ± 3.2690.00030.556 ± 4.12230.778 ± 4.328.3 ± 5.0780.262
Hospital admissions (n)1.542 ± 2.1671.811 ± 2.4261.942 ± 2.6530.8071.576 ± 2.2912.394 ± 3.021.909 ± 1.640.269
Length of stay (d)9.94 ± 11.8035.985 ± 8.4945.751 ± 7.9010.1376.588 ± 9.236.692 ± 8.4816.727 ± 10.0310.998
MAC (cm/mm)25.032 ± 2.51523.975 ± 3.59625.511 ± 2.9570.04524.779 ± 3.31924.853 ± 2.90324.696 ± 3.640.989
BIA-phase angle (°)6.82 ± 3.9126.348 ± 2.7776.805 ± 2.6450.6866.903 ± 3.2496.275 ± 2.425.474 ± 1.3230.238
MELD12.444 ± 5.21710.704 ± 5.12510.62 ± 3.8990.3508.647 ± 3.51313.683 ± 3.02817.208 ± 5.3020.000